Daisy L. Wilson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daisy L. Wilson has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Jyoti Ahlawat
The Department of Chemistry & Biochemistry, The University of Texas at El Paso, El Paso, TX 79968, USA
1 shared publication - Mahesh Narayan
The University of Texas at El Paso, USA
1 shared publication
Latest Publications
- Open Access
- 16 January 2024
- Published by MDPI AG in Journal of Nanotheranostics
- Vol. 5 (1) , 1-12
The Role of Fullerenes in Neurodegenerative Disorders
The use of carbon nanomaterials including fullerenes, carbon nanotubes, carbon nano-onions, carbon dots and carbon quantum dots for environmental applications has increased substantially. These nanoparticles are now used in the development of sensors and switches, in agriculture as smart fertilizers and in the biomedical realm for cancer therapy intervention, as antioxidants, in gene delivery and as theranostics. Here, we review the role of fullerenes as neuroprotectants. Their sp2 hybridized architectures and ability to intervene in the soluble-to-toxic transformation of amyloidogenic trajectories is highlighted here, along with other physico–chemical properties that impact interventional efficacy. Also highlighted are drawbacks that need to be overcome and future prospects.
- 16 January 2024
- Published by MDPI AG in Journal of Nanotheranostics
- Vol. 5 (1) , 1-12
Open AccessThe Role of Fullerenes in Neurodegenerative Disorders
The use of carbon nanomaterials including fullerenes, carbon nanotubes, carbon nano-onions, carbon dots and carbon quantum dots for environmental applications has increased substantially. These nanoparticles are now used in the development of sensors and switches, in agriculture as smart fertilizers and in the biomedical realm for cancer therapy intervention, as antioxidants, in gene delivery and as theranostics. Here, we review the role of fullerenes as neuroprotectants. Their sp2 hybridized architectures and ability to intervene in the soluble-to-toxic transformation of amyloidogenic trajectories is highlighted here, along with other physico–chemical properties that impact interventional efficacy. Also highlighted are drawbacks that need to be overcome and future prospects.